Diagnostic Approach and Treatment for West Nile Virus Infection

Diagnostic Approach

The primary diagnostic method for West Nile virus infection is serologic testing for virus-specific IgM and IgG antibodies in serum and/or cerebrospinal fluid (CSF), according to the Centers for Disease Control and Prevention 1
IgM antibodies to WNV are detectable 3-8 days after symptom onset and typically decrease after 2-3 months, though they may persist in serum for up to 12 months, as reported by the Clinical Infectious Diseases journal 1
Seroconversion to anti-WNV IgM and/or IgG positivity between acute and convalescent sera (collected 7-10 days apart) strongly suggests recent WNV infection, as stated by the Clinical Infectious Diseases journal 1
The presence of anti-WNV IgG alone indicates prior WNV infection, necessitating evaluation for alternative diagnoses, according to the Clinical Infectious Diseases journal 1
CSF testing is important for diagnosing neuroinvasive disease, and detection of IgM antibodies to WNV in CSF indicates CNS infection, as reported by the Clinical Infectious Diseases journal 1
Nucleic Acid Amplification Testing (NAAT) is more sensitive in immunosuppressed patients due to delayed immune response and prolonged viremia, as stated by the Clinical Infectious Diseases journal 1
Optimal specimens for NAAT include CSF, plasma, and serum, as recommended by the Morbidity and Mortality Weekly Report 2

Screening of asymptomatic pregnant women for WNV infection is not recommended, according to the Morbidity and Mortality Weekly Report 2, 3
Pregnant women with meningitis, encephalitis, acute flaccid paralysis, or unexplained fever in areas with ongoing WNV transmission should be tested for WNV antibodies in serum and CSF, as recommended by the Morbidity and Mortality Weekly Report 2, 3

No FDA-approved specific antiviral therapy exists for WNV infection, and treatment is primarily supportive care, as reported by the Clinical Infectious Diseases journal 4
High-dose intravenous corticosteroids (methylprednisolone, 1g IV daily for 3-5 days) are generally recommended for acute disseminated encephalomyelitis (ADEM) associated with WNV, according to the Clinical Infectious Diseases journal 4

Personal protective measures, such as applying insect repellent to skin and clothes and wearing protective clothing, are essential for preventing WNV infection, as recommended by the Morbidity and Mortality Weekly Report 2, 3

The Centers for Disease Control and Prevention recommends management of West Nile virus infection, including intravenous fluid administration, electrolyte supplementation, and nutritional support, as the mainstay of treatment 5

The American College of Obstetricians and Gynecologists suggests that detailed ultrasound examination of the fetus should be considered 2-4 weeks after onset of WNV illness, and testing of amniotic fluid, chorionic villi, or fetal serum may be considered, though sensitivity and specificity are unknown 6

The Centers for Disease Control and Prevention recommends personal protective measures, including avoiding outdoor activities during peak mosquito-feeding times, as part of community-based mosquito control programs 6

The Centers for Disease Control and Prevention recommends CSF IgM antibodies as the gold standard for confirming neuroinvasive disease, with a sensitivity of less than 60% in immunocompetent hosts, but more sensitive in immunosuppressed patients due to delayed immune response and prolonged viremia 7
The Infectious Diseases Society of America suggests that NAAT has limited sensitivity in immunocompetent hosts, but is more sensitive in immunosuppressed patients, and should be considered primarily in immunocompromised patients who may lack adequate serologic response 7

The Clinical and Laboratory Standards Institute recommends that CSF and serum specimens should be transported at room temperature within 2 hours for optimal testing 7
The World Health Organization suggests that CSF is the critical specimen for confirming CNS infection through IgM detection, and serum should be collected simultaneously for IgM and IgG testing 7

The American College of Medical Genetics recommends that IgM antibodies may persist for >6 months, potentially causing confusion about timing of infection, and cross-reactivity can occur with recent immunization or other flavivirus infections 7
The National Institute of Allergy and Infectious Diseases suggests that CSF IgM may be falsely negative during the first week of symptoms, so repeat testing may be necessary if clinical suspicion remains high 7